PubMed Health⌕ Search

Biomedical subjects

S A Rae

Publications and source records attributed to S A Rae.

11 recordsLinked to original sources

Artificial neural networks: a potential role in osteoporosis.

Artificial neural networks are computer software systems that recognize patterns in complex data sets. A recent development in neural computing, multiversion systems (MVS), has led to enhanced analytical power, and this was harnessed to demonstrate the value of risk factors in predicting the result of osteoporosis investigations by quantitative ultrasound. 274 women were screened in an open-access osteoporosis service. A conventional risk factor questionnaire was completed for each patient by the osteoporosis specialist nurse. An MVS was trained on 180 randomly selected data sets and tested on the remaining 94. The results were compared with those from logistic regression analysis in predictive power, both from the selected 20-item questionnaire and for a limited 5-item questionnaire comprising age, height, height loss, weight and years since the menopause. The MVS approach predicted the T-score categorization of the patients from the 20-item questionnaire with 83.0% accuracy, whereas logistic regression yielded an accuracy of only 72.8% (P = 0.04). From the 5-item database the MVS yielded a best prediction accuracy of 73.1%, whereas the logistic regression prediction accuracy was 60% (P = 0.04). These results suggest that 20 risk factors can be used by an MVS to predict the outcome of osteoporosis investigations with a power that outperforms conventional statistical methods. Use of this system may improve the selection of patients for osteoporosis investigations, since even with only 5 risk factors the system performs nearly as well as that based on the full 20 factors.

Aged↗

Designing a Back Management Service: the Exeter experience and first year results.

BACKGROUND: The recent British Clinical Standards Advisory Group report on back pain highlighted the importance of primary care in the active management of acute back pain and, at the same time, recommended the establishment of rehabilitation services for those with subacute and chronic back pain. OBJECTIVE: To describe a new Back Management Service (BMS) in Exeter and to review the first year's results. METHODS: Analysis of observational data collected from the clinic and therapy database. ASSESSMENTS: Clinic outcome assessed by diagnostic and referral patterns as well as by general practitioner questionnaire. The Back Management Programme was assessed by Short Form 36 (SF36), Hospital Anxiety and Depression score (HAD) and Oswestry Disability Index (ODI). RESULTS: In the first year 297 patients were seen in the clinic; clinic triage resulted in confirmation of primary care diagnosis in 235 (79%) of patients, with diagnosis revised in 62 (21 %). One hundred and eighty-nine (63.6%) patients were referred for therapy. Of these, 54 were referred for one-to-one therapy and 135 were referred for multidisciplinary review with 29 patients subsequently recruited into the Back Management Programme for rehabilitation. Two out of three outcome measures were significantly improved at the end of the 36-hour, four-week course. CONCLUSIONS: A Back Management Service can provide useful diagnostic reassessment of patients with chronic low back pain, and can focus therapeutic effort for the effective management of their pain.

Adult↗

Development and use of a gastropathy index for ranking the safety of non-steroidal anti-inflammatory drugs in the elderly.

This study, conducted at the Royal Devon & Exeter Hospital, Department of Geriatric Medicine, was carried out using 2987 sets of admission data. The number of patients taking non-steroidal anti-inflammatory drugs was identified together with a suite of clinical factors used to indicate the presence of gastrointestinal pathology. From this a gastropathy index was developed to establish a rank order for the individual drugs. Ketoprofen, piroxicam and fenbufen were all significantly associated with factors suggestive of gastropathy, whereas indomethacin, diclofenac and ibuprofen appeared relatively free of such association. Naproxen, azapropazone and mefenamic acid ranked in an intermediate category. This noninvasive analysis of routinely acquired data provides a potentially useful discriminator between individual non-steroidal anti-inflammatory drugs for this age group.

Aged↗

Leukotriene B4, a mediator of inflammation present in synovial fluid in rheumatoid arthritis.

Leukotriene B4 (LTB4), generated from arachidonic acid following lipoxygenase activity by a variety of inflammatory leucocytes, has been shown to be present in synovial fluid from patients with active rheumatoid arthritis. It does not persist as such, being converted to less active metabolites. The role of LTB4 as one of the natural mediators of inflammation is discussed.

Adult↗

Leukotriene B4, an inflammatory mediator in gout.

Leukotriene B4 (LTB4), a metabolite of arachidonic acid and a potent cytotaxin, is generated by human peripheral polymorphonuclear leucocytes (PMNs) exposed to monosodium urate crystals (MSU). The leukotriene is present in gouty effusions in concentrations significantly greater than those found in synovial fluid from patients with active rheumatoid arthritis or osteoarthritis. Further metabolism and biological deactivation of LTB4 by PMNs are partly inhibited by MSU. It is concluded that LTB4 is an important chemical mediator in an acute gouty attack.

Acute Disease↗

Alteration of plasma prednisolone levels by indomethacin and naproxen.

Eleven patients with stable rheumatoid disease (RD) who were receiving regular corticosteroid therapy (CS) were investigated to discover the effect on plasma prednisolone levels of additional therapy with the non-steroidal anti-inflammatory (NSAI) drugs, indomethacin and naproxen. There was a highly significant (P less than 0.001) increase in free prednisolone levels after concurrent therapy with either indomethacin or naproxen for 2 weeks. Total prednisolone levels were unchanged. These results could provide an explanation for clinical reports that these two NSAI drugs possess a steroid-sparing effect.

Aged↗